Amanpreet Kaur

About

I am passionate about translating novel drug delivery systems based on lipids and polymers into commercial therapeutic products with experience in nanoparticles/ liposomes based modalities.

Hands on experience in molecular biology, protoplast extraction, transformations, PCR, qPCR, DNA extraction, protein purification, electrophoresis, bioprocessing technologies etc.

Excellent communication, leadership, interpersonal skills, presentation skills, motivated team player, excellent time management with multitasking, supervising, strategic planning and conflict resolution skills.

Employment

• Delhi Pharmaceutical Science and Research University Assistant Professor
  2022 - Present
• St Louis Community College Senior Research Scientist and CRO Coordinator
  2020 - 2020
• St Louis Community College- CTC Geneomics Research Intern
  2019 - 2019
• Rayat and Bahra Institute of Pharmacy Assistant Professor
  2008 - 2012

Education

• Panjab University Ph.D
  2012 - 2017
• Punjabi University M.Pharmacy
  2006 - 2008
• Punjabi University B. Pharmacy
  2002 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (31)

• Nanoengineered supramolecular vesicular assemblies of diflunisal as a potential armor in treatment of psoriasis
  Journal of Drug Delivery Science and Technology 2026 DOI: 10.1016/j.jddst.2026.108269
  +Save
• Fabrication and characterization of prednisolone acetate-loaded electrospun mucoadhesive nanofibers for treatment of oral lichen planus
  Naunyn-Schmiedeberg's Archives of Pharmacology 2026 DOI: 10.1007/s00210-026-05189-w
  +Save
• Nanocarrier armor for siRNA delivery to address fracture risk in osteoporosis
  AAPS Open 2026 DOI: 10.1186/s41120-025-00143-1
  +Save
• A Comprehensive Review on the Growing Potential of Novel Nanocarriers in Psoriasis Therapy
  Current Pharmaceutical Design 2026 DOI: 10.2174/0113816128390836251208051331
  +Save
• Nucleic Acid-Based Therapeutic Delivery System
  Novel Drug Delivery Approaches from Fundamentals to Advanced Carrier Systems 2026 DOI: 10.1201/9781003508601-8
  +Save
• Co-supplementation of fructooligosaccharide with soy isoflavone restores the gut-brain axis dysfunction via modulation of gut microbiome in estrogen-deprived rat model
  Molecular Biology Reports 2026 DOI: 10.1007/s11033-026-12492-5
  +Save
• Gut microbiota metabolic axis dysfunction in estrogen deficient stressed rats
  Naunyn-Schmiedeberg's Archives of Pharmacology 2025 DOI: 10.1007/s00210-025-04399-y
  +Save
• Biosimilars: A Critical Review of Development, Regulatory Landscape, and Clinical Implications
  AAPS PharmSciTech 2025 DOI: 10.1208/s12249-025-03038-2
  +Save
• Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases
  Critical Reviews in Microbiology 2025 DOI: 10.1080/1040841X.2024.2391488
  +Save
• Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Treatment of Colorectal Diseases
  Application of Self Nanoemulsifying Drug Delivery Systems in Infammatory Diseases 2025 DOI: 10.1201/9781032697475-10
  +Save